A BILL 
To amend the Federal Food, Drug, and Cosmetic Act to 
prevent the abuse of dextromethorphan, and for other 
purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘DXM Abuse Preven-
4
tion Act of 2019’’. 
5
SEC. 2. SALES OF OVER-THE-COUNTER DRUGS CONTAINING 
6
DEXTROMETHORPHAN. 
7
(a) PROHIBITED ACTS.— 
8
03:06 Feb 08, 2019
H863
2 
•HR 863 IH
(1) VERIFICATION SYSTEM.—Section 301 of the 
1
Federal Food, Drug, and Cosmetic Act (21 U.S.C. 
2
331) is amended by adding at the end the following: 
3
‘‘(fff) The failure of a retailer (as defined in section 
4
506H) that offers for sale in interstate commerce covered 
5
drugs (as defined in section 506H) to have a verification 
6
system as required by section 506H (relating to sales of 
7
over-the-counter drugs containing dextromethorphan).’’. 
8
(2) IDENTIFIER
FOR
ELECTRONIC
OF 
9
SALE SYSTEM; ACTIVE INGREDIENTS.—Section 301 
10
of the Federal Food, Drug, and Cosmetic Act (21 
11
U.S.C. 331), as amended by paragraph (1), is fur-
12
ther amended by adding at the end the following: 
13
‘‘(ggg) The introduction or delivery for introduction 
14
into interstate commerce of any covered drug (as defined 
15
in section 506H) whose labeling does not include— 
16
‘‘(1) a universal product code, universal product 
17
number, bar code, or similar identifier to allow an 
18
electronic point of sale system to recognize that the 
19
sale of the covered drug is prohibited to those under 
20
the age of 18; and 
21
‘‘(2) the established name of each active ingre-
22
dient of the covered drug within the first panel of 
23
the drug facts labeling required by section 201.66(c) 
24
of title 21, Code of Federal Regulations (or any suc-
25
03:06 Feb 08, 2019
H863
3 
•HR 863 IH
cessor regulations), in no smaller than 6-point 
1
type.’’. 
2
(b) VERIFICATION SYSTEM.—The Federal Food, 
3
Drug, and Cosmetic Act is amended by inserting after sec-
4
tion 506G of such Act (21 U.S.C. 356g) the following: 
5
‘‘SEC. 506H. SALES OF OVER-THE-COUNTER DRUGS CON-
6
TAINING DEXTROMETHORPHAN. 
7
‘‘(a) VERIFICATION SYSTEM.—Any retailer selling or 
8
offering for sale in interstate commerce a covered drug 
9
shall have a verification system in accordance with this 
10
section that is intended to ensure that no individual who 
11
purchases a covered drug from the retailer is under 18 
12
years of age. Such a system shall be set up to prompt 
13
a retailer to examine a purchaser’s identification card. 
14
‘‘(b) MEANS USED TO ENSURE COMPLIANCE.—A 
15
verification system under subsection (a) may ensure com-
16
pliance with this section by any of, or any combination 
17
of, the following means: 
18
‘‘(1) An electronic point-of-sale system that is 
19
coded— 
20
‘‘(A) to prompt for verification of the age 
21
of purchasers of covered drugs; and 
22
‘‘(B) to deny sales of covered drugs to 
23
those under the age of 18. 
24
03:06 Feb 08, 2019
H863
4 
•HR 863 IH
‘‘(2) Training manuals, materials, or programs 
1
that instruct employees— 
2
‘‘(A) to verify the age of purchasers of cov-
3
ered drugs; and 
4
‘‘(B) to deny sales of covered drugs to 
5
those under the age of 18. 
6
‘‘(3) Signage in and around the sales counter 
7
outlining the age restriction on sales of covered 
8
drugs. 
9
‘‘(4) Designating one on-duty employee to ap-
10
prove sales of covered drugs. 
11
‘‘(5) Any other verification measure adopted by 
12
a retailer that is designed to ensure that a purchaser 
13
of a covered drug is not under 18 years of age if, 
14
based on an examination of the purchaser’s identi-
15
fication card, the retailer reasonably concludes the 
16
identification card is valid and indicates the pur-
17
chaser is not under 18 years of age. 
18
‘‘(c) EXCEPTIONS.— 
19
‘‘(1) INDIVIDUALS OVER 26.—A verification sys-
20
tem 
under 
subsection 
(a) 
need 
not 
require 
21
verification of the age of any individual over the age 
22
of 26. 
23
‘‘(2) VALID PRESCRIPTION.—A verification sys-
24
tem under subsection (a) need not apply to any sale 
25
03:06 Feb 08, 2019
H863
5 
•HR 863 IH
made by a retailer that is a pharmacy pursuant to 
1
a validly issued prescription. 
2
‘‘(3) VALID MILITARY IDENTIFICATION CARD.— 
3
A verification system under subsection (a) need not 
4
apply to any sale to an individual who supplies proof 
5
at the time of such sale that such individual is ac-
6
tively enrolled in the military and presents a valid 
7
military identification card. 
8
‘‘(d) ENFORCEMENT.—In carrying out this section, 
9
the Secretary shall coordinate with State entities that reg-
10
ulate retailers, as designated by the State, to perform ac-
11
tivities to ensure compliance with this section, including 
12
providing for appropriate investigation of complaints re-
13
lated to violations of this section. 
14
‘‘(e) COMPLIANCE WITH STATE SYSTEM.—If a State 
15
has a law under which a retailer in the State is required 
16
to have a system that ensures that no individual who pur-
17
chases a covered drug from the retailer is under 18 years 
18
of age, the Secretary shall treat any such retailer in the 
19
State that is in compliance with such law as having a 
20
verification system as required by this section, including 
21
for purposes of sections 301(fff) and 303(h). 
22
‘‘(f) DEFINITIONS.—In this section: 
23
‘‘(1) The term ‘covered drug’— 
24
‘‘(A) means a drug that— 
25
03:06 Feb 08, 2019
H863
6 
•HR 863 IH
‘‘(i) contains dextromethorphan; and 
1
‘‘(ii) 
is 
not 
subject 
to 
section 
2
503(b)(1); and 
3
‘‘(B) excludes any drug that is packaged in 
4
packets or pouches and contains 2 or fewer 
5
maximum adult doses of dextromethorphan as 
6
allowable under section 341.74 of title 21, Code 
7
of Federal Regulations (or any successor regu-
8
lations). 
9
‘‘(2) The term ‘identification card’ means an 
10
identification card that— 
11
‘‘(A) includes a photograph and the date of 
12
birth of the individual; and 
13
‘‘(B) is issued by a State or the Federal 
14
Government or is considered acceptable for pur-
15
poses 
of 
sections 
274a.2(b)(1)(v)(A) 
and 
16
274a.2(b)(1)(v)(B)(1) of title 8, Code of Fed-
17
eral Regulations (including any successor regu-
18
lations). 
19
‘‘(3) The term ‘retailer’ means— 
20
‘‘(A) a grocery store, general merchandise 
21
store, drug store, pharmacy, convenience store, 
22
or other entity whose activities as a seller of 
23
covered drugs containing dextromethorphan are 
24
limited almost exclusively to sales for personal 
25
03:06 Feb 08, 2019
H863
7 
•HR 863 IH
use, both in number and volume of sales, in-
1
cluding any sales made by the Internet or other 
2
means; and 
3
‘‘(B) excludes any entity listed in subpara-
4
graph (A) that does not sell any covered drug 
5
described in paragraph (1)(A).’’. 
6
(c) CIVIL PENALTIES.—Section 303 of the Federal 
7
Food, Drug, and Cosmetic Act (21 U.S.C. 333) is amend-
8
ed by adding at the end the following: 
9
‘‘(h) A retailer that violates section 301(fff) shall not 
10
be subject to subsection (a) or any civil monetary penalty 
11
under this Act for such violation except as follows: 
12
‘‘(1) If the Secretary finds that a retailer fails 
13
to have a verification system in violation of section 
14
301(fff)— 
15
‘‘(A) upon the first such finding, the Sec-
16
retary shall issue a formal notice of violation 
17
and give the retailer a period of at least 30 
18
days (beginning on the receipt of such notice) 
19
to correct the violation; 
20
‘‘(B) upon the second such finding, the re-
21
tailer shall be subject to a civil penalty of not 
22
more than $1,000; 
23
03:06 Feb 08, 2019
H863
8 
•HR 863 IH
‘‘(C) upon the third such finding, the re-
1
tailer shall be subject to a civil penalty of not 
2
more than $2,000; and 
3
‘‘(D) upon the fourth and any subsequent 
4
such finding, the retailer shall be subject to a 
5
civil penalty of not more than $5,000. 
6
‘‘(2) In determining the amount of a civil pen-
7
alty under this subsection for a retailer, the Sec-
8
retary shall consider whether the retailer has taken 
9
appropriate steps to prevent subsequent violations, 
10
such as the establishment and administration of a 
11
documented employee training program to ensure all 
12
employees are familiar with, and abiding by, the re-
13
tailer’s verification system established pursuant to 
14
section 506H, where such program includes— 
15
‘‘(A) educating employees regarding cov-
16
ered drugs; 
17
‘‘(B) instruction on the correct method of 
18
checking a purchaser’s identification card; and 
19
‘‘(C) notifying employees of the civil pen-
20
alties under this subsection. 
21
‘‘(3) If a retailer transacts sales of covered 
22
drugs at more than one physical location, for pur-
23
poses of determining the number of violations by 
24
that retailer under this subsection, each individual 
25
03:06 Feb 08, 2019
H863
9 
•HR 863 IH
physical location operated by that retailer shall be 
1
considered a separate retailer. 
2
‘‘(4) The Secretary shall notify retailers found 
3
to have violated section 301(fff) as soon as prac-
4
ticable after the Secretary discovers such violation. 
5
Such notification shall include the date and time 
6
when the failure to have a verification system as re-
7
quired by such section was observed to occur. 
8
‘‘(5) In this subsection, the terms ‘covered 
9
drug’ and ‘retailer’ have the meanings given such 
10
terms in section 506H.’’. 
11
(d) APPLICABILITY.—The amendments made by sub-
12
sections (a), (b), and (c) shall apply with respect to drugs 
13
sold or offered for sale on or after the date that is one 
14
year after the date of enactment of this Act. 
15
(e) SENSE OF CONGRESS REGARDING COMMUNICA-
16
TION BY ORGANIZATIONS NOMINATED BY MANUFACTUR-
17
ERS.—It is the sense of Congress that organizations nomi-
18
nated by manufacturers of covered drugs (as defined in 
19
section 506H of the Federal Food, Drug, and Cosmetic 
20
Act, as added by subsection (c)) should make reasonable 
21
efforts to communicate to retailers (as defined in such sec-
22
tion 506H) the requirements of such section 506H, includ-
23
ing by making available upon request materials (which 
24
may include signage, manuals, materials, or programs) to 
25
03:06 Feb 08, 2019
H863
10 
•HR 863 IH
assist with educating employees regarding such covered 
1
drugs. 
2
SEC. 3. RESTRICTIONS ON DISTRIBUTION OF BULK DEX-
3
TROMETHORPHAN. 
4
(a) IN GENERAL.—The Federal Food, Drug, and 
5
Cosmetic Act is amended— 
6
(1) in section 301 (21 U.S.C. 331) (as amended 
7
by section 2(a)) by adding at the end the following: 
8
‘‘(hhh) The possession, receipt, or distribution of un-
9
finished dextromethorphan in violation of section 506I.’’; 
10
(2) by inserting after section 506H (as added 
11
by section 2(b)) the following: 
12
‘‘SEC. 506I. RESTRICTIONS ON THE DISTRIBUTION OF BULK 
13
DEXTROMETHORPHAN. 
14
‘‘(a) IN GENERAL.—No person shall— 
15
‘‘(1) possess or receive unfinished dextrome-
16
thorphan, unless the person is registered under sec-
17
tion 510 or otherwise registered, licensed, or ap-
18
proved pursuant to Federal or State law to engage 
19
in— 
20
‘‘(A) the practice of pharmacy; or 
21
‘‘(B) drug or drug ingredient discovery, 
22
production, manufacture, or distribution; or 
23
03:06 Feb 08, 2019
H863
11 
•HR 863 IH
‘‘(2) distribute unfinished dextromethorphan to 
1
any person other than a person described in para-
2
graph (1). 
3
‘‘(b) EXCEPTION
FOR COMMON CARRIERS.—This 
4
section does not apply to a common carrier that possesses, 
5
receives, or distributes unfinished dextromethorphan for 
6
purposes of distributing such unfinished dextromethor-
7
phan between persons described in subsection (a). 
8
‘‘(c) DEFINITIONS.—In this section: 
9
‘‘(1) The term ‘common carrier’ means any per-
10
son that holds itself out to the general public as a 
11
provider for hire of the transportation by water, 
12
land, or air of merchandise, whether or not the per-
13
son actually operates the vessel, vehicle, or aircraft 
14
by which the transportation is provided, between a 
15
port or place and a port or place in the United 
16
States. 
17
‘‘(2) The term ‘unfinished dextromethorphan’ 
18
means dextromethorphan that is not contained in a 
19
drug that is in finished dosage form.’’; and 
20
(3) by amending section 303, as amended by 
21
section 2(c), by adding at the end the following: 
22
‘‘(i) A person that violates section 301(hhh) shall not 
23
be subject to subsection (a) or any civil monetary penalty 
24
under this Act for such violation except such person shall 
25
03:06 Feb 08, 2019
H863
12 
•HR 863 IH
be subject to a civil penalty in an amount of not more 
1
than $100,000.’’. 
2
(b) APPLICABILITY.—The amendments made by this 
3
section apply beginning on the date of enactment of this 
4
Act. 
5
Æ 
03:06 Feb 08, 2019
H863
